Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Aripiprazole (Excl. Dafo For The Production Of A Dis), (Obo) Atc N05Ax12 For The Period 01.02.2025 - 31.01.2027

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 99891147

  Document Type - Tender Notices

Description - Description: Scope of procurementBrief descriptionSection 130a paragraph 8 of the Social Code Book V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the drugs dispensed at the expense of t he statutory health insurance companies. In view of the relevant legal provisions for awarding public contracts, a regular process of active substance-related, formal award procedures takes place through DAK-Gesundheit in accordance with the regulations of Part 4 of the GWB. For drugs containing the above-mentioned active substance, aripiprazole (only dosage forms for the manufacture of a depot injection suspension), ATC N05AX12, which are to be

Gt Ref Id - 99891147

Deadline - Dec 04, 2026